Please login to the form below

Not currently logged in
Email:
Password:

New asthma training for nurses

A programme to help provide practice nurses with additional knowledge about the causes and management of asthma has been launched in the UK

A programme to help provide practice nurses with additional knowledge about the causes and management of asthma has been launched in the UK.

The ASCEND programme, 'Asthma skills, Continued Education and Nurse Development' intends to bridge the gap between pre-registration training and more specialist, post-graduate learning. 

The initiative has been developed by a steering group of primary and secondary care respiratory nurses with nurse representatives from Asthma UK, Education for Health, Primary Care Respiratory Society UK (PCRS-UK) and Respiratory Education UK (REUK) in partnership with and funded by MSD.

It will be available as a printed resource and also online via the Nursing in Practice website.

Stephanie Wolfe, chair of the PCRS-UK Nurse committee said: "Asthma remains an important chronic disease affecting people of all ages and walks of life. ASCEND is an excellent starting point for nurses and other healthcare professionals working in this field."

Research conducted by Education for Health has shown that over 50 per cent of nurses conducting diagnostic or follow up consultations have no formal training in asthma, this is in part due to staff shortages and lack of funding.

Erica Haines, asthma lead for Education for Health said: "Continuing professional education and training is essential for all nurses. ASCEND is designed to provide a foundation in asthma knowledge which can be further developed through postgraduate education."

19th August 2010

From: Healthcare

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...

Infographics